The minimally abnormal Papanicolaou smear

American Family Physician

Volumn 53, Issue 4, 1996, Pages 1154-1162

  Brotzman, Gregory L ^a   Julian, Thomas M ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLAMYDIASIS; COLPOSCOPY; ENDOMETRIUM CELL; HUMAN; HYPERKERATOSIS; PAPANICOLAOU TEST; PARAKERATOSIS; PRACTICE GUIDELINE; REVIEW; SEXUALLY TRANSMITTED DISEASE; SQUAMOUS EPITHELIUM; TRICHOMONIASIS; UTERINE CERVIX CARCINOMA IN SITU;

CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CLINICAL PROTOCOLS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; SPECIMEN HANDLING; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 0029867935     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Herbst AL. The Bethesda system for cervical/vaginal cytologic diagnoses: a note of caution [Editorial]. Obstet Gynecol 1990;76(3 Pt 1):449-50.
2. Kurman RJ, Malkasian GD Jr, Sedlis A, Solomon D. From Papanicolaou to Bethesda: the rationale for a new cervical cytologic classification. Obstet Gynecol 1991;77:779-82.
3. Koss LG. The Papanicolaou test for cervical cancer detection. A triumph and a tragedy. JAMA 1989; 261:737-43.
4. Kurman RJ, Henson DE, Herbst AL, Noller KL, Schiffman MH. Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop. JAMA 1994;271:1866-9.
5. Kurman RJ, Solomon D. The Bethesda system for reporting cervical/vaginal cytologic diagnoses. New York: Springer-Verlag, 1994.
6. Busseniers AE, Sidawy MK. Inflammatory atypia on cervical smears. A diagnostic dilemma for the gynecologist. J Reprod Med 1991;6:85-8.
7. Pearlstone AC, Grigsby PW, Mutch DG. High rates of atypical cervical cytology: occurrence and clinical significance. Obstet Gynecol 1992;80:191-5.
8. Lindheim SR, Smith-Nguyen G. Aggressive evaluation for atypical squamous cells in Papanicolaou smears. J Reprod Med 1990;35:971-3.
9. Spitzer M, Krumholz BA, Chernys AE, Seltzer V, Lightman AR. Comparative utility of repeat Papanicolaou smears, cervicography, and colposcopy in the evaluation of atypical Papanicolaou smears. Obstet Gynecol 1987;69:731-5.
10. Ridgley R, Hernandez E, Cruz C, Miyazawa K. Abnormal Papanicolaou smears after earlier smears with atypical squamous cells. J Reprod Med 1988;33:285-8.
11. Kaminski PF, Stevens CW Jr, Wheelock JB. Squamous atypia on cytology. The influence of age. J Reprod Med 1989;34:617-20.
12. American College of Obstetrics and Gynecology. Cervical cytology: evaluation and management of abnormalities. ACOG technical bulletin no. 183. Washington, D.C.: ACOG, 1993:1-7.
13. Slawson DC, Bennett JH, Herman JM. Are Papanicolaou smears enough? Acetic acid washes of the cervix as adjunctive therapy a HARNET study. J Fam Pract 1992;35(3):271-7.
14. Ottaviano M, La Torre P. Examination of the cervix with the naked eye using acetic acid test. Am J Obstet Gynecol 1982;143:139-42.
15. Massad LS, Lonky NM, Mutch DG, Mann WJ, Blanco JS, Vasilev SA, et al. Use of speculoscopy in the evaluation of women with atypical Papanicolaou smears. Improved cost effectiveness by selective colposcopy. J Reprod Med 1993;38:163-9.
16. Jones DE, Creasman WT, Dombroski RA, Lentz SS, Waeltz JL. Evaluation of the atypical Pap smear. Am J Obstet Gynecol 1987;157:544-9.
17. Montz FJ, Monk BJ, Fowler JM, Nguyen L. Natural history of the minimally abnormal Papanicolaou smear. Obstet Gynecol 1992;80(3 Pt 1):385-8.
18. Nasiell K, Roger V, Nasiell M. Behavior of mild cervical dysplasia during long-term follow-up. Obstet Gynecol 1986;67:665-9.
19. Noumoff JS. Atypia in cervical cytology as a risk factor for intraepithelial neoplasia. Am J Obstet Gynecol 1987;156:628-31.
20. Andrews S, Miyazawa K. The significance of a negative Papanicolaou smear with hyperkeratosis or parakeratosis. Obstet Gynecol 1989;73(5 Pt 1):751-3.
21. Johnson CA, Lorenzctti LA, Liese BS, Ruble RA. Clinical significance of hyperkeratosis on otherwise normal Papanicolaou smears. J Fam Pract 1991; 33(4):354-8.
22. Lawley TB, Lee RB, Kapela R. The significance of moderate and severe inflammation on class I Papanicolaou smear. Obstet Gynecol 1990;76:997-9.
23. Brown MS, Phillips GL Jr. Management of the mildly abnormal Pap smear: a conservative approach. Gynecol Oncol 1985;22:149-53.
24. Weinberger MW, Harger JH. Accuracy of the Papanicolaou smear in the diagnosis of asymptomatic infection with Trichomonas vaginalis. Obstet Gynecol 1993;82:425-9.
25. Spence MR, Barbacci M, Kappus E, Quinn T. A correlative study of Papanicolaou smear, fluorescent antibody, and culture for the diagnosis of Chlamydia trachomatis. Obstet Gynecol 1986;68:691-5.
26. Foulkes SJ, Deighton R, Feeney AR, Mohanty KC, Freeman CW. Comparison of direct immunofluorescence and cell culture for detecting Chlamydia trachomatis. Genitourin Med 1985;61 255-7.
27. Goff BA, Atanasoff P, Brown E, Muntz HG, Bell DA, Rice LW. Endocervical glandular atypia in Papanicolaou smears. Obstet Gyneccol 1992;79 101-4.
28. Peters RK, Chao A, Mack TM, Thomas D, Bernstein L, Henderson BE. Increased frequency of adenocarcinoma of the uterine cervix in young women in Los Angeles County. J Natl Cancer Inst 1986;76:423-8.
29. Van Le L, Novotny D, Dotters DJ. Distinguishing tubal metaplasia from endocervical dysplasia on cervical Papanicolaou smears. Obstet Gynecol 1991;78(5 Pt 2):974-6.
30. Novotny DB, Maygarden SJ, Johnson DE, Frable WJ. Tubal metaplasia. A frequent potential pitfall in the cytologic diagnosis of endocervical glandular dysplasia on cervical smears. Acta Cytol 1992;36:1-10.
31. Cherkis RC, Patten SF Jr, Andrews TJ, Dickinson JC, Patten FW. Significance of normal endometrial cells detected by cervical cytology. Obstet Gynecol 1988;71:242-4.
32. Valle RF. Hysteroscopic evaluation of patients with abnormal uterine bleeding. Surg Gynecol Obstet 1981;153:521-6.
33. Fink DJ. Change in American Cancer Society Checkup Guidelines for detection of cervical cancer. CA Cancer J Clin 1988;38:127-8.
34. Sedlacek T. Clinical options in dealing with minor cytologic abnormalities. Colposcopist 1992;24(4):1-2.
35. Shy K, Chu J, Mandelson M, Greer B, Figge D. Papanicolaou smear screening interval and risk of cervical cancer. Obstet Gynecol 1989;74 838-43.
36. Kivlahan C, Ingram E. Papanicolaou smears without endocervical cells. Are they inadequate? Acta Cytol 1986;30:258-60.
37. Taylor PT Jr, Andersen WA, Barber SR, Covell JL, Smith EB, Underwood PB Jr. The screening Papanicolaou smear, contribution of the endocervical brush. Obstet Gynecol 1987;70:734-8
38. McCord ML, Stovall TG, Meric JL, Summitt RL Jr, Coleman SA. Cervical cytology: a randomized comparison of four sampling methods. Am J Obstet Gynecol 1992;166(6 Pt 1):1777-9.
39. Julian T. The minimally abnormal Pap smear and cervical cancer screening. Colposcopist 1993;25(3):1-6.